SCHEMBL13585073

SCHEMBL13585073

N[C@@H](CS(=O)(=O)N1CCNCC1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.36
▸ DPP7 Q9UHL4 1/20 0.35
▸ KYNU Q16719 2/20 0.34
▸ NOS2 P35228 1/20 0.34
▸ PMP22 Q01453 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ GCLC P48506 1/20 0.33
▸ PTGS1 P23219 1/20 0.32
▸ SLC7A11 Q9UPY5 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ F13A1 P00488 1/20 0.32
▸ TGM2 P21980 1/20 0.32
▸ TGM1 P22735 1/20 0.32
▸ GRIK1 P39086 2/20 0.31
▸ SLC7A5 Q01650 1/20 0.31
▸ GRM8 O00222 1/20 0.31
▸ GRM6 O15303 1/20 0.31
▸ GRIN2D O15399 1/20 0.31
▸ GRIN3B O60391 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13585075 1.00 KMT2A (0.44) KMT2AKDM4EDPP7KYNUNOS2
SCHEMBL1768580 0.85 PMP22 (0.43) KMT2AKDM4EDPP7PMP22ALDH1A1
SCHEMBL13585760 0.85 PMP22 (0.43) KMT2AKDM4EDPP7PMP22ALDH1A1
SCHEMBL13585217 0.84 DPP7 (0.46) DPP7KYNUNOS2PMP22GCLC
SCHEMBL13585382 0.84 DPP7 (0.42) DPP7KYNUNOS2PMP22GCLC
SCHEMBL13585384 0.84 DPP7 (0.42) DPP7KYNUNOS2PMP22GCLC
SCHEMBL13585214 0.84 DPP7 (0.46) DPP7KYNUNOS2PMP22GCLC
SCHEMBL13585764 0.82 DPP7 (0.49) KMT2ADPP7KYNUNOS2PMP22
SCHEMBL13585762 0.82 DPP7 (0.49) KMT2ADPP7KYNUNOS2PMP22
SCHEMBL13585342 0.79 L3MBTL1 (0.37) KDM4EDPP7KYNUNOS2PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8754038-B2 Template-fixed peptidomimetics with CCR10 antagonistic activity POLYPHOR AG (CH) 2014-06-17 — — US disclosed
US-20120283168-A1 TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVITY POLYPHOR AG (CH) 2012-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283168-A1 TEMPLATE-FIXED PEPTIDOMIMETICS WITH CCR10 ANTAGONISTIC ACTIVITY CCR10, CCR1, CCRL2 KMT2A 3431/4885KDM4E 4722/4885DPP7 1414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback